News
Center for Clinical Trial Innovation furthers FDA’s diversity goals, rare disease drug development
19 April 2024
The U.S. Food and Drug Administration (FDA) has announced the establishment of the “Center for Drug Evaluation (CDER) Center for Clinical Trial Innovation” (C3TI). C3TI is...